Skip to main content
SCM Lifescience Co., Ltd. logo

SCM Lifescience Co., Ltd. — Investor Relations & Filings

Ticker · 298060 ISIN · KR7298060005 KO Manufacturing
Open in API
Filings indexed 418 across all filing types
Latest filing 2021-08-17 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 298060

About SCM Lifescience Co., Ltd.

http://www.scmlifescience.com/en/

SCM Lifescience Co., Ltd. is a biotechnology company focused on developing high-purity, high-efficacy stem cell therapeutics for difficult-to-treat and incurable diseases. The company utilizes its proprietary source technology, the Subfractionation Culturing Method, to isolate and culture potent stem cells. Its pipeline consists of allogeneic stem cell therapies targeting immunological conditions, which are undergoing clinical trials. SCM Lifescience is also establishing mass production manufacturing processes using 3D bioreactor technology and expanding its research into induced pluripotent stem cells (iPSC) and tissue engineering. The company's business areas also include contract manufacturing (CMO), contract research, consulting, and cosmetics.

Recent filings

Filing Released Lang Actions
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for SCM Lifescience Inc. for the period ending June 30, 2021. It contains comprehensive financial and operational information, including company overview, history, capital changes, and governance details, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-17 Korean
주식매수선택권부여에관한신고
Remuneration Information Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options). It details the issuance of stock options to specific employees and executives, including the number of shares, exercise price, and legal basis. This type of disclosure regarding capital changes and equity-based compensation is classified as a share issue or capital change announcement.
2021-08-13 Korean
기타경영사항(특허권취득)(자율공시)(조절 T 세포 매개성 질환의 예방 또는 치료용 약학적 조성물)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from SCM Lifescience regarding the acquisition of a patent for a pharmaceutical composition. It is categorized as a 'voluntary disclosure' (자율공시) in the Korean regulatory context. Since it does not fit into specific categories like financial reports, board changes, or share transactions, and is a standard regulatory announcement of a corporate event, it falls under the 'Regulatory Filings' (RNS) category.
2021-07-21 Korean
[기재정정]반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for SCM Lifescience Co., Ltd. It contains detailed financial information, business descriptions, capital changes, and management discussions for the period ending June 30, 2020. It is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). H1 2020
2021-07-21 Korean
[기재정정]분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for SCM Lifescience Co., Ltd. covering the period from January 1, 2020, to September 30, 2020. It contains detailed financial data, management discussions, and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2021-07-21 Korean
[기재정정]사업보고서 (2020.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for a previously filed 2020 Annual Report (사업보고서). It details specific corrections made to the financial and management disclosures (such as fund usage and management status) of the original annual report. In the context of Korean financial filings (DART system), a correction to an annual report is classified as part of the 10-K (Annual Report) filing category, as it represents an amendment to the official yearly performance and activity report. FY 2020
2021-07-21 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.